Haemonetics (HAE) Up 4.4% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 03/10/22
Haemonetics to Present at Raymond James 43rd Annual Institutional Investors ConferencePRNewsWire • 02/23/22
Haemonetics Corporation (HAE) CEO Christopher Simon on Q3 2022 Results - Earnings Call TranscriptSeeking Alpha • 02/08/22
Haemonetics 3rd Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations WebsitePRNewsWire • 02/08/22
Haemonetics (HAE) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 02/01/22
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2022 Results: February 8, 2022PRNewsWire • 01/05/22
Haemonetics Corporation's (HAE) CEO Chris Simon on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 11/09/21
Haemonetics 2nd Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations WebsitePRNewsWire • 11/09/21
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2022 Results: November 9, 2021PRNewsWire • 10/06/21
Haemonetics Announces VASCADE MVP® Venous Vascular Closure System Gains the First and Only FDA Approval for Same-Day Discharge Following Atrial Fibrillation AblationPRNewsWire • 09/30/21